Agree! Just want to comment that AEMD was scheduled to present clinical data resulting from the treatment of Hepatitis-C (HCV) infected patients with the Aethlon Hemopurifier® at the 42nd Annual Meeting & Scientific Exposition of the American Society of Nephrology (ASN). Dr. Vijay Kher, principal investigator of the Hemopurifier® studies and Director of Nephrology at the Fortis Hospital in New Delhi, India will present and discuss Hemopurifier® treatment results from 10am-12pm pacific time on October 30th, 2009. The event is being held at The San Diego Convention Center in San Diego, California.
As of 11am today the clinical data from this meeting was not released to the newswires yet. Not sure why, but I am waiting for it ... Also the company is scheduled to meet with the FDA sometime over the next month or so + their scheduled Quarterly earnings release on 11/16 should all be catalysts for the stock price.